Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 96 entries
View as:

Tumour Characterisation to Guide Experimental Targeted Therapy - National

Phase: N/A Priority: Normal
NCT ID: NCT04723316 Org: User:
Start: 06/30/21 End: 01/30/28 Due: 01/30/29

Tissue Sample Collection From Patients With Soft Tissue Sarcoma of the Arms, Hands, Legs, or Feet Treated on Clinial Trial CRUK-VORTEX

Phase: N/A Priority: Normal
NCT ID: NCT00900211 Org: User:
Start: 08/31/07 End: - Due: -

TIL Therapy in Metastatic Melanoma and IL2 Dose Assessment

Phase: N/A Priority: Normal
NCT ID: NCT01995344 Org: User:
Start: 03/01/14 End: 07/24/15 Due: 07/24/16

Second-line Therapy for Patients With Progressive Poorly Differentiated Extra-pulmonary Neuroendocrine Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03837977 Org: User:
Start: 11/13/18 End: 11/26/24 Due: 11/26/25

Development of a Patient Reported Outcome Measure for Advanced Ovarian Cancer Patients Receiving Surgical and Chemotherapy Treatment

Phase: N/A Priority: Normal
NCT ID: NCT05274867 Org: User:
Start: 03/07/22 End: 06/07/22 Due: 06/07/23

Impact of COVID-19 on Lung Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT04538456 Org: User:
Start: 10/15/20 End: 04/16/22 Due: 04/16/23

Effect of Pelvic Radiotherapy on the Intestinal Microbiome and Metabolome

Phase: N/A Priority: Normal
NCT ID: NCT04995809 Org: User:
Start: 07/05/21 End: 07/21/23 Due: 07/21/24

Remote Monitoring of Patients at Risk of Sepsis

Phase: N/A Priority: Normal
NCT ID: NCT04260230 Org: User:
Start: 03/31/22 End: 12/19/24 Due: 12/19/25

Circulating Tumour DNA Guided Adaptive BRAF and MEK Inhibitor Therapy

Phase: N/A Priority: Normal
NCT ID: NCT06470880 Org: User:
Start: 06/30/24 End: 06/30/27 Due: 06/30/28

CAcTUS - Circulating Tumour DNA Guided Switch

Phase: N/A Priority: Normal
NCT ID: NCT03808441 Org: User:
Start: 05/02/19 End: 05/02/24 Due: 05/02/25

Study to Determine the Feasibility of Sentinel Node Biopsy in Patients With Anal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02162641 Org: User:
Start: 09/30/14 End: 05/31/15 Due: 05/31/16

PreOperative Brain Irradiation in Glioblastoma

Phase: N/A Priority: Normal
NCT ID: NCT03582514 Org: User:
Start: 04/19/22 End: 06/30/25 Due: 06/30/26

Multi-maintenance Olaparib After Disease Recurrence in Participants With Platinum Sensitive BRCAm High Grade Serous Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02855697 Org: User:
Start: 05/26/17 End: 12/31/21 Due: 12/31/22

Development and Validation of a Patient Reported Experience Measure for Experimental Cancer Medicine

Phase: N/A Priority: Normal
NCT ID: NCT05386602 Org: User:
Start: 07/16/18 End: 11/20/23 Due: 11/20/24

Exploratory Study of EBV DNA Titre Clearance Whilst on Proton Beam Therapy

Phase: N/A Priority: Normal
NCT ID: NCT06480903 Org: User:
Start: 08/30/24 End: 08/30/26 Due: 08/30/27

MEK Inhibitor and Thoracic Radiotherapy Trial

Phase: N/A Priority: Normal
NCT ID: NCT01146756 Org: User:
Start: 06/04/10 End: 02/08/17 Due: 02/08/18

Dual REctcal Angiogenesis or MEK Inhibition radioTHERAPY Trial

Phase: N/A Priority: Normal
NCT ID: NCT01160926 Org: User:
Start: 07/31/10 End: 11/04/16 Due: 11/04/17

Feasibility of Utilising Brushing Cytology and Dermoscopy for Diagnosing Penile Lesions

Phase: N/A Priority: Normal
NCT ID: NCT05662839 Org: User:
Start: 01/31/23 End: 01/31/24 Due: 01/31/25

The Use of Rectal Balloons in Radical Pelvic Radiotherapy - a Feasibility Study

Phase: N/A Priority: Normal
NCT ID: NCT01842750 Org: User:
Start: 08/31/13 End: - Due: -

Upper GI Serial Tumour Biopsies

Phase: N/A Priority: Normal
NCT ID: NCT05233007 Org: User:
Start: 01/25/22 End: 10/31/28 Due: 10/31/29

Circulating Tumour DNA guidEd Therapy for Stage IIB/C mElanoma After surgiCal resecTION

Phase: N/A Priority: Normal
NCT ID: NCT04901988 Org: User:
Start: 11/08/21 End: 01/30/23 Due: 01/30/24

A Pilot Study Using Magnetic Resonance (MR) to Assess Cervix Motion During Radiotherapy Treatment.

Phase: N/A Priority: Normal
NCT ID: NCT03101306 Org: User:
Start: 09/01/17 End: 03/01/19 Due: 03/01/20

Patient Experience of Consent for Cancer Surgery in Light of Recent Changes to UK Law- a Questionnaire Study

Phase: N/A Priority: Normal
NCT ID: NCT04024189 Org: User:
Start: 04/01/18 End: 08/10/18 Due: 08/10/19

Interleukin-2 With or Without Histamine Dihydrochloride in Treating Patients With Metastatic Kidney Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00005038 Org: User:
Start: 06/30/99 End: - Due: -

Erbitux Study of CPT11, Oxaliplatin, UFToral Targeted Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01225744 Org: User:
Start: 04/30/09 End: 05/31/13 Due: 05/31/14